Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Compensatory and maladaptive responses to cardiac dysfunction

G S Francis1, C Chu

  • 1Department of Medicine, University of Minnesota Medical School, Minneapolis 55455, USA.

Current Opinion in Cardiology
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Effectiveness and safety of rivaroxaban in pediatric patients with coronary artery diseases: a case series study].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2026
Same author

[Artificial intelligence in hypertension: advances and challenges].

Zhonghua xin xue guan bing za zhi·2025
Same author

[Analysis of 41 cases of myocardial infarction in children with coronary artery lesion after Kawasaki disease].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2025
Same author

[Relationship between clopidogrel resistance and genetic variability in Kawasaki disease children with coronary artery lesions].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2024
Same author

Perspectives on long-acting formulations of pre-exposure prophylaxis (PrEP) among men who have sex with men who are non-adherent to daily oral PrEP in the United States.

BMC public health·2023
Same author

Facilitators for retaining men who have sex with men in pre-exposure prophylaxis care in real world clinic settings within the United States.

BMC infectious diseases·2022
Same journal

Contemporary medical management of left ventricular assist device patients: integrating sex-specific perspectives.

Current opinion in cardiology·2026
Same journal

Viability testing for guiding revascularization in ischemic cardiomyopathy.

Current opinion in cardiology·2026
Same journal

An integrative approach to patient selection for mitral transcatheter edge-to-edge repair in secondary mitral regurgitation.

Current opinion in cardiology·2026
Same journal

Rebooting blood vessel repair: implications of the SEMA-VR CardioLink-15 trial.

Current opinion in cardiology·2026
Same journal

Advancements in wearable technology for heart failure patients.

Current opinion in cardiology·2026
Same journal

Minimally invasive approaches to coronary artery bypass grafting: techniques, current evidence, and future directions.

Current opinion in cardiology·2026
See all related articles

Advances in heart failure treatment focus on the neurohormonal model, exploring drugs to inhibit neuroendocrine activity. Future trials will assess beta-adrenergic blockers for improved patient outcomes and understanding heart failure pathophysiology.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pharmacology

Background:

  • Congestive heart failure (CHF) research is shifting from hemodynamic to neurohormonal models.
  • Neurohormone imbalance is increasingly recognized as a key factor in CHF pathophysiology.
  • Therapeutic strategies now emphasize interrupting neuroendocrine activity.

Purpose of the Study:

  • To review recent clinical trials and ongoing research in congestive heart failure.
  • To highlight the potential of neuroendocrine inhibitors, particularly beta-adrenergic blockers, in CHF treatment.
  • To underscore the need for further understanding of CHF's basic biology and pathophysiology.

Main Methods:

  • Review of recent clinical trials and scientific literature on heart failure.

Related Experiment Videos

  • Investigation of neurohormone imbalance manifestations in clinical settings.
  • Study of various animal models of heart failure.

    • Main Results:

    • Clinical trials support the use of drugs inhibiting neuroendocrine activity.
    • Beta-adrenergic blocking drugs show promise but require large-scale trials.
    • Studies confirm neurohormone imbalance in heart failure patients, with reduced heart rate variation being a focus.

    Conclusions:

    • Significant advances in heart failure treatment have been made, improving survival.
    • Current treatments extend survival but increase long-term care costs.
    • Understanding basic heart failure biology is crucial for developing earlier therapies and prevention strategies.